• Home (Dutch)
  • Contact
  •  EN 
  • Employee login

Collaborations for Research


​​​Together with an increase in external research funding and publications in recognized journals, the number of valuable collaborations and partnerships the UMCG is involved in, is growing.

Below collaborations are being showed in two categories: National and International Collaborations


President Vladimir Putin of the Russian Federation and Dutch Prime Minister Mark Rutte watched as Folkert Kuipers, Dean and vice-chairman of the Board of Directors of the UMCG, signed a cooperation agreement aimed at establishing a stem cell institute in Skolkovo, Russia. President Edward Crawley and director Nikolai Yankovsky signed the agreement on behalf of the Russian partners, the Skolkovo Institute of Science and Technology (Skoltech) and the Vavilov Institute of General Genetics, respectively. Signing this agreement was an official part of Putin’s visit to the Netherlands on April 8 to mark the start of the Netherlands-Russia bilateral year.


National Collaborations

Aim: Biobanking and Biomolecular Resources Research Infrastructure NL is the Dutch hub within the European BBMRI project.
Participants: Eight Dutch UMC’s, Parelsnoer Institute, NKI, RIVM, VUA, WUR, UU

Parelsno​er Institute
Aim: Collection of clinical data and biomaterials from the eight UMC’s, 9 medical conditions / pearls
Participants: Eight Dutch UMC’s

Mouse Center for Cancer and Aging Research (MCCA), ultramodern research facility, cutting edge expertise in mouse engineering technologies
Participants: ERIBA (UMCG), NKI, Brains On-Line

Top Institute Pharma (TIP), public-private partnership, multidisciplinary research, development of socially valuable medicines
Participants: Universities, UMC’s, SMEs, large industry, patient organizations, national government

Aim: Center for Translational Molecular Medicine (CTMM), public-private partnership, innovator of Molecular Diagnostics and Molecular Imaging technologies, personalized treatment of patients.
Participants: Universities, UMC’s, SMEs, large industry, patient organizations, health foundations, national government

Aim: BioMedical Materials programme (BMM), public-private partnership, develop new therapies and products to combat organ and tissue failure
Participants: Universities, UMC’s, SMEs, large industry, health foundations, national government

Aim: Top Institute Food and Nutrition (TIFN), public-private partnership, strategic research in food and nutrition.
Participants: Leading food and ingredient manufacturers and personal care companies, research institutes and universities including university medical centers

Aim: Healthy Ageing Network Northern Netherlands (HANNN), knowledge and development cluster in the field of healthy ageing.
Participants: Research and knowledge institutes, SMEs and large industry, regional authorities in the Northern Netherlands

Aim: Carbohydrate Competence Center (CCC), generate and develop high-quality knowledge in the field of carbohydrates, stimulating innovation, contributing to a healthier and more sustainable society
Participants: UMCG, RUG, Wageningen UR, TNO and SMEs

Aim: Smart Prevention, Rehabilitation & INtervention Technologies at home for improved mobility (SPRINT), increase mobility of elderly
Participants: UMCG, RUG, University of Twente and tens of SMEs

Aim: Center for Medical Imaging North East Netherlands (CMINEN), innovative medical imaging, research & development, education and valorisation.
Participants:UMCG, RUG, University of Twente, Siemens Netherlands

Aim: Netherlands Consortium for Healthy Ageing (NCHA), study of biological factors that keep people healthy and reduce the risk of disease and disability
Participants: LUMC, EMCR, UMCG, WUR, VUmc, AMC, Unilever, Philips, Galápagos, McRoberts, Pfizer and DSM


Strategic International Partnerships

Oldenburg-Groningen Joint Graduate Research Training Group
Aim: The binational, interdepartmental and interdisciplinary joint degree PhD program aims to foster the integration of basic research, patient-oriented research, and population-based research with the long-term aim to improve health and patient outcome.
Participants: UMCG, University of Groningen, Carl von Ossietzky Universität Oldenburg

Alliance for Healthy Aging
Aim: Transatlantic collaboration, advance the development of tools that enable older individuals to live independently
Participants: UMCG, RUG, Mayo Clinic (USA), VitaValley, PGGM, Noaber Foundation

Aim: Life sciences network, North Eastern Europe, regional research driven clusters
Participants: Life sciences clusters from Scandinavia, Baltic Sea Region, Poland and Germany

Skolkovo Center for Stem Cell Research
Aim: Set up a new institute for research into stem cells, expand fundamental knowledge of stem cells and advance the study of stem cells in Russia
Participants: ERIBA (UMCG), MIT (Boston, USA), Hubrecht Institute (Utrecht, Netherlands), 4 Russian Research institutes

Aim: Biobanking and Biomolecular Resources Research Infrastructures, interface between biological specimens and data and top-level biological and medical research
Participants: European Universities and Research Institutes, EU national governments

Aim: Transatlantic intitiative, biobanking, biology of ageing research, systems biology, multidisciplinary research and innovation
Participants: UMCG, Universities of Copenhagen, Newcastle, McGill (CA), British Colombia (CA), Mayo Clinic (USA)

East-West Alliance
Aim: Network of Asian and Western medical education and research institutions
Participants: Not yet defined


Large International Projects

Aim: FP7 project, Training of early stage and experienced researchers in the field of Ageing Research: telomere and cell senescence biology, using a variety of models and technological approaches.
Participants: UMCG, 7 universities and 4 companies

Aim: FP7 project, Biobank Standardisation and Harmonisation for Research Excellence in the European Union
Participants: UMCG, 15 EU and Canadian universities

Aim: FP7 project, BBMRI-Large Prospective Cohort, unites the large study sets of BBMRI and the International Agency for Research on Cancer (IARC), achieving a worldwide unique scale of integration
Participants: 30 partners

Aim: FP7 project, resolving the disturbed dynamics and mechanisms underlying the high triglyceride and low HDL cholesterol phenotype and insulin resistance in patients with the metabolic syndrome and its associated co-morbidities
Participants: UMCG, 9 universities and 3 companies

Aim: FP7 project, Intervention Research On Health Literacy among Ageing Population, improving health literacy for the older people in Europe
Participants: UMCG, 6 EU universities, 5 health institutes, 4 advocacy organizations and 6 SMEs